Acro Biomedical Co., Ltd. (ACBM)

OTCMKTS · Delayed Price · Currency is USD

0.0260

0.00 (0.00%)

At close: Apr 20, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017
Wholesale - Drugs				658.50K	1.20M	687.96K		-	-
Wholesale - Drugs Growth				-45.01%	74.06%	-		-	-
Recreational Activities				-	-	-		1.35M	8.01M
Recreational Activities Growth				-	-	-		-83.11%	1471.47%
Total				658.50K	1.20M	687.96K		1.35M	8.01M
Total Growth				-45.01%	74.06%	-		-83.11%	1471.47%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017
United States				658.50K	1.20M	687.96K		1.35M	8.01M
United States Growth				-45.01%	74.06%	-		-83.11%	1471.47%
Total				658.50K	1.20M	687.96K		1.35M	8.01M
Total Growth				-45.01%	74.06%	-		-83.11%	1471.47%

Source: S&P Global Market Intelligence.